(ADMA) Adma Biologics complete technical analysis [charts+indicators] | Buy/Sell Adma Biologics | (ADMA) share price targets
Complete technical analysis of Adma Biologics (ADMA) by charts plus indicators, forecast predictions and share price targets for Adma Biologics (ADMA)
Adma Biologics trades in USA in Health Care sector.
Showing technical analysis as on 2025-06-10 View latest technical analysis
10 day averaged volume of Adma Biologics is 2164260
| Date | Daily Closing Price | Open | High | Low | Volume |
| 10 Tue Jun 2025 | 20.86 | 20.98 | 21.39 | 20.42 | 1.153 times |
| 09 Mon Jun 2025 | 20.87 | 21.00 | 21.37 | 20.72 | 1.067 times |
| 06 Fri Jun 2025 | 20.61 | 20.17 | 20.65 | 20.08 | 0.633 times |
| 05 Thu Jun 2025 | 19.94 | 20.26 | 20.49 | 19.77 | 0.719 times |
| 04 Wed Jun 2025 | 20.33 | 20.35 | 20.79 | 20.25 | 0.673 times |
| 03 Tue Jun 2025 | 20.46 | 20.37 | 20.62 | 20.13 | 1.226 times |
| 02 Mon Jun 2025 | 20.43 | 19.85 | 20.44 | 19.55 | 1 times |
| 30 Fri May 2025 | 19.84 | 19.85 | 20.09 | 19.28 | 1.289 times |
| 29 Thu May 2025 | 19.77 | 19.63 | 20.14 | 19.40 | 1.089 times |
| 28 Wed May 2025 | 19.51 | 19.88 | 20.08 | 19.50 | 1.027 times |
My analysis of stock is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if stock stays above 20.5, but if it comes below 20.5, then a intra day sell could be more profitable.
If you take a sell trade below 20.5, then use 20.5 as stoploss and 20.1 as target. However if you take a buy trade in stock , then use 20.5 as stoploss and 21.1 as target.
Share price targets for Adma Biologics (ADMA)
| Target Type | Value |
| Downside Target | 13.50 |
| Downside Target | 15.17 |
| Downside Target | 16.51 |
| Downside Target | 17.20 |
| Downside Target | 18.75 |
| Downside Target | 20.42 |
| Downside Target | 20.73 |
| Downside Target | 20.79 |
| Downside Target | 20.82 |
| Upside Target | 21.39 |
| Upside Target | 24.19 |
| Upside Target | 25.67 |
Intraday share price targets for Adma Biologics (ADMA)
| Target Type | Value |
| Downside Intraday Target | 20.39 |
| Downside Intraday Target | 19.92 |
| Upside Intraday Target | 21.36 |
| Upside Intraday Target | 21.86 |
| Upside Intraday Target | 20.89 |
Weekly technical analysis of Adma Biologics (ADMA)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 10 Tue Jun 2025 | 20.86 | 21.00 | 21.39 | 20.42 | 0.522 times |
| 06 Fri Jun 2025 | 20.61 | 19.85 | 20.79 | 19.55 | 0.908 times |
| 30 Fri May 2025 | 19.84 | 20.45 | 20.53 | 19.28 | 0.978 times |
| 23 Fri May 2025 | 20.42 | 19.65 | 20.73 | 19.51 | 0.576 times |
| 16 Fri May 2025 | 19.69 | 19.75 | 20.82 | 18.95 | 0.644 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Adma Biologics (ADMA)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 10 Tue Jun 2025 | 20.86 | 19.85 | 21.39 | 19.55 | 0.196 times |
| 30 Fri May 2025 | 19.84 | 24.19 | 24.19 | 18.75 | 0.885 times |
| 30 Wed Apr 2025 | 23.80 | 19.83 | 25.67 | 16.51 | 1.186 times |
| 31 Mon Mar 2025 | 19.84 | 16.45 | 20.64 | 13.50 | 1.738 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adma Biologics (ADMA)
Price action analysis of Adma Biologics ( (ADMA) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adma Biologics ( (ADMA) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adma Biologics ( (ADMA) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adma Biologics ( (ADMA) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Adma Biologics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adma Biologics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Adma Biologics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adma Biologics in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Adma Biologics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 20.26 and Adma Biologics (ADMA) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Adma Biologics (ADMA) stock. Volume based technical analysis of Adma Biologics (ADMA) stock is negative.
Adma Biologics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adma Biologics ( (ADMA) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adma Biologics ( (ADMA) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adma Biologics ( (ADMA) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adma Biologics ( (ADMA) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Adma Biologics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adma Biologics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Adma Biologics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adma Biologics in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Adma Biologics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 20.26 and Adma Biologics (ADMA) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Adma Biologics (ADMA) stock. Volume based technical analysis of Adma Biologics (ADMA) stock is negative.
Adma Biologics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.